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Baltimore, MarylandABSTRACT Lateral heterogeneity of cell membranes has been demonstrated in numerous studies showing anomalous diffu-
sion of membrane proteins; it has been explained by models and experiments suggesting dynamic barriers to free diffusion, that
temporarily confine membrane proteins into microscopic patches. This picture, however, comes short of explaining a steady-
state patchy distribution of proteins, in face of the transient opening of the barriers. In our previous work we directly imaged
persistent clusters of MHC-I, a type I transmembrane protein, and proposed a model of a dynamic equilibrium between proteins
newly delivered to the cell surface by vesicle traffic, temporary confinement by dynamic barriers to lateral diffusion, and disper-
sion of the clusters by diffusion over the dynamic barriers. Our model predicted that the clusters are dynamic, appearing when an
exocytic vesicle fuses with the plasma membrane and dispersing with a typical lifetime that depends on lateral diffusion and the
dynamics of barriers. In a subsequent work, we showed this to be the case. Here we test another prediction of the model, and
show that changing the stability of actin barriers to lateral diffusion changes cluster lifetimes. We also develop a model for the
distribution of cluster lifetimes, consistent with the function of barriers to lateral diffusion in maintaining MHC-I clusters.INTRODUCTIONThe fluid mosaic model of cell membrane organization
emphasizes the autonomy and lateral mobility of membrane
proteins and lipids; the model characterizes membranes as
more fluid than mosaic (1). In recent years, it has become
clear that, in fact, membrane lipids and proteins associate
on many scales from protein dimers to multimolecular clus-
ters, to micrometer-size membrane domains (2,3). The
mechanisms of molecular associations and domain forma-
tion vary for different molecules and for different size-
scales. At the smallest scale, differences in interaction
energies among different proteins and lipids will lead to
differential associations and formation of small clusters of
membrane proteins and lipids. At larger length-scales these
small clusters can be stabilized and their size enhanced by
constraints to lateral diffusion. Some of these constraints
arise in the actin-rich membrane skeleton (4). Other
constraints to lateral diffusion (which can therefore stabilize
molecular clusters) can be inferred from the anomalous
lateral diffusion of many membrane proteins (5).
Class I major histocompatibility complex (MHC) mole-
cules, type I transmembrane proteins, exhibit such con-
strained diffusion, as was demonstrated using fluorescence
recovery after photobleaching (FRAP) measurements. The
results were interpreted as a slow diffusion coefficient
(~1010 cm2 s1) within a protein-rich domain and a fast
(~109 cm2 s1) diffusion coefficient in the continuum
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were suggested to consist of cytoskeletal components (6).
This interpretation, consistent with the membrane-skeleton
fence model (7), further prompted the direct observation
of these protein-rich domains, delineated by cytoskeletal
fences, and predicted to be of ~200-nm dimensions from
single-particle tracking observations on other membrane
proteins (8). We used super-resolution, near-field scanning
optical microscopy (9) and also a deconvolution approach
to conventional micrographs (10) to directly image immu-
nolabeled MHC-I on the plasma membrane, and found
protein-rich domains with sizes of 300–700 nm. We also
estimated the number of molecules present in one such
domain to be 25–125 (9). This number was later measured
again using far-field microscopy and found to be 20–240
(10), consistent with the earlier estimation. We refer to these
protein-rich regions inferred from FRAP studies, delineated
by cytoskeletal barriers to free diffusion, and directly
imaged with near-field scanning optical microscopy and
far-field microscopy as clusters of MHC-I molecules.
Changes in the extent of class I MHC clustering have func-
tional consequences. Dispersal of small-scale clusters inter-
feres with the recognition of MHC molecules by effector
T-lymphocytes (11). Stabilizing larger clusters, by stabi-
lizing membrane skeleton’s actin, has the opposite effect,
enhancing recognition of MHC molecules by effector
lymphocytes (12).
The existence of MHC-I clusters, however, cannot be ex-
plained merely by the existence of barriers to free diffusion,
because these barriers were shown to be dynamic and allow
escape and diffusion of proteins out of the protein-rich
domains. Thus, a given cluster should disperse by diffusiondoi: 10.1016/j.bpj.2012.01.042
1544 Lavi et al.over the barriers in a relatively short time, and the persis-
tence of clusters must be maintained by some replenishing
mechanism. To better understand the persistence of MHC
clusters at steady state, we made a quantitative model based
on the proposal that protein clusters are maintained by
a combination of vesicle trafficking to and from the cell
surface (leading to local concentrations of newly delivered
membrane proteins), confinement of membrane proteins
by dynamic barriers, and the dispersion of individual clus-
ters by lateral diffusion (13). The model predicts that indi-
vidual clusters appear instantly at different points in time,
due to delivery of molecules by a fusing vesicle and the
temporary restraint of these newly delivered molecules by
fences; each cluster concentration decays with a character-
istic lifetime due to (restricted) diffusion over the cytoskel-
eton barriers.
The apparent size of the individual cluster also increases
with time, due to this diffusion over the barriers. The popu-
lation of clusters present on the membrane at any given
point in time is thus heterogeneous in size and concentra-
tion, because different clusters are born in different
moments and their size increases, whereas their concentra-
tion decreases with time. The model does not assume any
kind of interaction between the molecules; the simulated
clusters are formed solely due to a dynamic equilibrium
between continuous delivery of new molecules at distinct
locations on the plasma membrane and their temporary
restraint by the fences. Moreover, the model assumes the
delivery sites of new molecules are random. Despite this
dynamic and random picture, two-dimensional autocorrela-
tion of the simulated membrane captures a typical size and
extent of clustering (contrast or deviation from a uniform
random distribution of molecules). When studying the simu-
lated dynamics of individual simulated clusters, we pre-
dicted an exponential decay of their concentration, with
a typical 1/e lifetime of ~20 s.
To test this dynamic nature of the clusters, we used live
cells with GFP-tagged MHC-I combined with total internal
reflection fluorescence microscopy (TIRFM) real-time
imaging (14). We showed that the size and intensity of
a particular cluster varies with time. An example is shown
in Fig. 1: the waterfall plot in Fig. 1 D shows the intensity
profile (as a function of position) of a single cluster and
its progression with time. The cluster is born at an instant
(indicated in Fig. 1 C), followed by an exponential decay
in its intensity and a progressive widening. Various clusters
in a given frame have various sizes and intensities, depend-
ing on their age, number of molecules forming them, and
initial size (at the time of birth). A characteristic size can
be extracted by using two-dimensional autocorrelation of
the images, as we have shown in Hwang et al. (9) and
Gheber and Edidin (13) or by constructing a distribution
of individual sizes, as was shown in Tang and Edidin (10),
where the distribution of cluster sizes was found to be
approximately Gaussian, with a mean of ~320 nm and aBiophysical Journal 102(7) 1543–1550standard deviation of ~30 nm. This size distribution changes
(the mean size increases) upon inhibiting vesicle traffic to
the plasma membrane (10).
Fitting the time-dependent intensity of individual clusters
with a decaying exponential function, we extracted the
typical lifetime of individual clusters, constructed the life-
time distribution, and found the characteristic lifetime of
a cluster is ~35 s (14), in very good agreement with the
predictions of the model (13) and with other data on kinetics
of exocytic traffic (15).
In this article we characterize the lifetimes of MHC-I
clusters and compare the lifetime distributions resulting
from various drug treatments that stabilize or destabilize
the actin of the plasma membrane skeleton; our model
(13) predicts that these treatments should affect the lifetime
of MHC-I clusters. Stabilizing actin, a likely component of
barriers to lateral diffusion (12), is expected to prolong the
lifetime of a cluster of MHC molecules; destabilizing is ex-
pected to reduce this lifetime by removing some impedi-
ments to lateral diffusion. Here we show that this is the
case. We also investigate the shape of the distribution of
cluster lifetimes and develop a model that emphasizes the
importance of barriers to lateral diffusion in determining
cluster lifetime.MATERIALS AND METHODS
All reagents were purchased from Biological Industries, Kibbutz Beit Hae-
mek, Israel, unless otherwise noted.Cell culture
Normal mouse fibroblasts (L-M(tk)) expressing MHC I, H2-Ld with their
intracellular region tagged with GFP (GFP-in) (13) were cultured in
250-mLTC flasks (CELSTAR tissue culture dishes; Grenier Bio-One, Mon-
roe, NC) at 37C and 5% CO2 in Roswell Park Memorial Institute Medium
(RPMI-1640) without L-glutamine, with 10% Fetal Bovine Serum,
0.22 mg/mL G418 (Geneticin; Sigma, St. Louis, MO). The correct folding
and function of the GFP construct was validated and reported in Marguet
et al. (16); we thus assume it is a faithful reporter of the endogenous
MHC-I population.Cell mounting
Cells were detached from flasks by incubating in 2 mL Trypsin EDTA
0.25% for 10 min at 37C, and transferred to homemade glass bottom petri
dishes, in 4 mL medium. After overnight incubation, medium was removed
and dishes were gently rinsed three times and imaged in 0.5 mL warmed
(37C) HEPES Hanks’ balanced salt solution.Treatments
Cells were incubated for 30 min at 37C in 10 or 20 mMPhalloidin (Sigma),
or in 100 or 200 nM Latrunculin A (Sigma). Subsequently, the cells were
gently rinsed three times and imaged in 5 mL warmed (37C), drug-free,
HEPES Hanks’ balanced salt solution, for 1 h. Higher concentrations of
Latrunculin A proved to result in observable shape change of the cells,
FIGURE 1 Comparison between epi-fluores-
cence and TIRF imaging. (A) Epi-fluorescence
image of two GFP-tagged MHC-I fibroblasts.
The nuclei (dark) are visible and patches of fluo-
rescence are not well localized. (B) The same
two cells, in the same focal plane, imaged using
TIRFM. Cells appear two-dimensional, the
membrane contour is sharp, and the MHC-I clus-
ters are easily distinguished (see zoomed-in inset).
(Circle, inset) Example of selection of a clearly
distinguishable cluster. (C) A time-dependent plot
of the average intensity in an area as was indicated
(see circle in panel B). In this particular case, a new
delivery is observed (indicated by an arrow). The
intensity decays exponentially with time both
before and after the delivery. The data after the
delivery is fitted with an exponential decay (solid
line). (D) Intensity profiles as a function of position
of the cluster analyzed in panel C, at 10 different
time points (see waterfall plot). The profiles are
laterally displaced along the x axis for clarity, to
form a pseudo-three-dimensional view of the
spatial evolution of a single cluster with time; there
is no lateral motion of the cluster peak in reality.
(Arrow) Time progresses from back to front. The
cluster intensity and dimensions are seen to change
with time: the cluster is bright and narrow upon
delivery, becoming dimmer and wider as time
progresses.
Control of MHC-I Lifetime by Actin Cytoskeleton 1545and were not used in experiments. At 200 nM Latrunculin A, the cells main-
tained their shape, with good adhesion.Imaging
Imaging was performed in drug-free HEPES Hanks’ balanced salt solution.
Imaging was carried out on a homemade prism-based total internal reflec-
tion fluorescence microscopy (TIRFM) system, using an Argon-ion laser
(2213-75SLY; Uniphase, San Jose, CA) at 488 nm as the excitation light
source. Digital images were acquired with a SPOT charge-coupled device
camera (Diagnostic Instruments, Sterling Heights, MI), mounted on an
Axioplan2 upright light microscope with a 40, 0.8 NA water dipping
objective (Carl Zeiss Microimaging, Peabody, MA), as previously
described in Lavi et al. (14). TIRFM excludes the fluorescence originating
in the cell cytoplasm and allows observation of the clusters on the plasma
membrane only, as seen in the comparison between panels A and B in Fig. 1.
Time series were acquired, 5-min-long each, for a total of 1 h, of the same
field. Exposure times ranged between 1 and 2.5 s per frame, depending on
the brightness of the cells under investigation. These exposure times are
short compared with the dynamics we are sampling (tens of seconds) and
were found to be an optimal compromise between low noise and high pho-
tobleaching. One-h-long time series were analyzed separately for the first
30 min and last 30 min, to obtain information on the time dependence of
the distributions.Image analysis
Image analysis was carried out using the software ImageJ (National
Institutes of Health, Bethesda, MD; available freely at http://imagej.nih.
gov/ij/), as follows.The inset of Fig. 1 B is a zoom-in of the area indicated and shows four
clearly distinguishable clusters. The circle around the bottom-right cluster
in the inset shows an example of definition of a region of interest (ROI).
Clusters were identified in this manner on one frame of a series, where it
was the most distinguishable from its background and the intensity of the
ROI (as a mean shaded value) was quantified throughout the series. The
intensity was plotted as a function of time, after background and photo-
bleaching corrections.
For each cluster, the time-dependent intensity was fitted with a single
exponential decay function of the form I(t) ¼ I0 þA exp (t/t), where I0
is the intensity for t ¼ N, t is the characteristic lifetime of the patch,
and A is its intensity above the background for t ¼ 0. Such a plot is shown
in Fig. 1 C, where a new delivery is also observed during the measurement.
The solid line represents an exponential fit as mentioned above. The indi-
vidual lifetimes (t) thus quantified for hundreds of clusters were then
used to construct distributions of lifetimes.Significance test
Lifetime distributions were all positively skewed and were fitted with











where t is the characteristic lifetime extracted from the exponential fit of
the intensity versus time trace of individual clusters, and tc is the most prob-
able value (the mode, or peak). When comparing distributions, we used the
mode as the measure of location of the distribution, because it is the mostBiophysical Journal 102(7) 1543–1550
1546 Lavi et al.intuitive and easy to identify (visually). However, to test significance of
differences between the mean lifetimes resulting from various treatments,
we compared the distributions of ln(t), which were found to be indistin-
guishable from normal distributions (by Shapiro-Wilk and Liliefors
normality tests). We then used a t-test on log-transformed data, to test the
null hypothesis that two distributions have the same mean.FIGURE 2 Lifetime distributions of MHC-I clusters on plasma
membrane of cells treated with (top panel) 200 nM Latrunculin A and
(bottom panel) 20 mM Phalloidin. (Middle panel) Distribution for clusters
of untreated cells. (Solid lines) Fit of log-normal distribution to the dataRESULTS AND DISCUSSION
Total internal reflection fluorescence microscopy (TIRFM)
is a well-established technique (14,17) that preferentially
excites fluorescence from the cell surface, while excluding
most fluorescence from the cytoplasm. GFP-tagged MHC-I
proteins traffic from the endoplasmic reticulum through the
Golgi complex to the surface. Hence, fluorescence is present
throughout the cell cytoplasm. TIRFM excludes this cyto-
plasmic fluorescence from the image, as shown in Fig. 1,
which compares conventional epifluorescence (Fig. 1 A)
and TIRF illumination (Fig. 1 B).
Clusters were identified in a frame of a stack of images, as
shown by the circular ROI in the inset of Fig. 1 B, and their
average (per pixel) intensity was quantified and plotted
against time, for the entire duration of the measurement,
as shown in Fig. 1 C. As predicted by our model (13), the
clusters are born at an instant (Fig. 1 C); their average inten-
sity decays exponentially with time (Fig. 1 C), and their size
increases with time (Fig. 1 D). The decrease of intensity
over time was fitted with an exponential decay function,
as discussed in Materials and Methods, after which a distri-
bution of lifetimes (extracted t) was constructed, in a similar
way as previously reported in Lavi et al. (14).points. (Vertical dashed line) Mode (peak) of the distribution for untreated
cells.Actin stabilization or destabilization changes
the lifetimes of MHC I clusters
To test the hypothesis that stabilizing or destabilizing actin
filaments alters cluster lifetime, by changing the dynamics
of the barriers that obstruct free diffusion, we treated cells
with drugs—Phalloidin and Lantrunculin A—which stabi-
lize or destabilize actin filaments, respectively. Phalloidin
binds to filamentous actin much more tightly than to actin
monomers, leading to a decrease in the dissociation of actin
subunits from filament ends. This stabilizes actin filaments
through the prevention of filament depolymerization (18).
Latrunculin A binds actin monomers more readily than
F-actin, thus preventing their incorporation into polymer-
izing F-actin filaments. Hence, it decreases the rate constant
for the association of actin monomers, destabilizing actin
filaments (19).
The distribution of cluster lifetimes for untreated cells
(control) is presented in Fig. 2 (middle panel); the modal
lifetime is 42 s, in agreement with our earlier result (14).
Treatment with 20 mM Phalloidin caused a shift toward
longer lifetimes, with a mode of 92 s, as shown in Fig. 2
(bottom panel). Treatment with 200 nM Latrunculin ABiophysical Journal 102(7) 1543–1550shifted cluster lifetimes toward shorter lifetimes with
a mode of 26 s, as shown in Fig. 2 (top panel). Analysis
of the log-transformed data showed that the average life-
times of clusters in drug-treated cells were significantly
different (p < 0.05) from those in untreated cells. Thus,
stabilization of actin filaments, which ought to hinder
dispersion of MHC-I molecules by lateral diffusion,
increases the lifetime of MHC-I clusters (Fig. 2, bottom),
whereas destabilization of actin filaments, which ought to
enhance cluster dispersion, decreases cluster lifetimes
(Fig. 2, top).The effect of Phalloidin and Latrunculin A on MHC
I cluster lifetimes is transient
Time series were acquired for cells treated with 20 mMPhal-
loidin for 1 h after a rinse and change to balanced salt solu-
tion. Comparing distribution of lifetimes acquired during
the first 30 min and during the following 30 min, it is evident
that the effect of treatment is reversible (Fig. 3). During the
first 30 min of imaging (Fig. 3 A), the modal cluster life time
FIGURE 3 Shift in cluster life times is transient for Phalloidin. (A) Life-
time of MHC-I clusters from cells incubated with 20 mM Phalloidin (iden-
tical with Fig. 2, bottom panel) imaged immediately after removing the
drug. (B) Lifetime of MHC-I clusters from same cells, 30 min after
removing the drug. (C) Lifetime of MHC-I clusters from untreated cells.
(Solid lines) Fit to log-normal distribution. (Vertical dashed line) Mode
(peak) of the distribution for 20 mM Phalloidin treatment. (Arrows) Gradual
shift toward shorter lifetimes, as the effect of Phalloidin is reduced.
FIGURE 4 Shift in cluster lifetimes is transient for Latrunculin. (A) Life-
time of MHC-I clusters from cells incubated with 200 nM Latrunculin
(identical with Fig. 2, top panel) imaged immediately after removing the
drug. (B) Lifetime of MHC-I clusters from same cells, 30 min after
removing the drug. (C) Lifetime of MHC-I clusters from untreated cells.
(Solid lines) Fit to log-normal distribution. (Vertical dashed line) Mode
(peak) of the distribution for 200 nM Latrunculin treatment. (Arrows)
Gradual shift toward longer lifetimes, as the effect of Latrunculin is
reduced.
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Fig. 2, bottom panel), whereas during the following 30 min,
a significantly (p < 0.05) shorter modal lifetime, 64 s is
measured. The effect of Phalloidin is thus transient.
Similar experiments with 200 nM Latrunculin A showed
that the decrease of cluster lifetime is transient as well, and
at 30-min posttreatment, a significant increase (p < 0.05) in
modal lifetime was measured, as shown in Fig. 4.Lifetime of MHC I clusters depends on dose
of treatment
Intermediate concentrations, 100 nM of Latrunculin A and
10 mM of Phalloidin gave intermediate cluster lifetimes,
as shown in Fig. 5. Thus it is possible to shift the character-
istic lifetimes of MHC-I clusters over a range of ~20–~90 s,
using this relatively simple protocol. The shift, although
transient, provides a time window of several tens of minuteswhen lifetimes are altered, and could be used to determine
the relationship between clustering and function, for
example in the recognition of MHC-I proteins by T cells.The source of log-normal distribution
of cluster lifetimes
The lifetime distributions presented here and previously
(14) are positively skewed, and we used the log-normal
distribution to fit the data and extract the distribution param-
eters (mainly the mode of the distribution) to infer signifi-
cance of effects induced by various treatments. In this
section we discuss the underlying factors that may lead to
this measured distribution of t.
Consider an initial high concentration (r) of molecules
(delivered by a vesicle) in a region of size R (determined
by the spacing between actin filaments), which then decays
as r(t) ~ exp(t/t); the lifetime t is given by t ¼ R2/D,
where D is the diffusion coefficient of the fluorescent
marker in the membrane. The distribution of decay timesBiophysical Journal 102(7) 1543–1550
FIGURE 5 Modal cluster lifetimes for MHC-I molecules on cells treated
with actin-modulating drugs. (Open bar, Control) Cluster lifetime of
untreated cells. (Shaded columns, Rec. (Recovery)) Lifetime measured
30-min post treatment with Latrunculin A (200 nM) or Phalloidin (20 mM),
as indicated. (Solid columns) Modal lifetime for cells treated with the indi-
cated drug concentration. (Error bars) Mean 5 SE for log-transformed
data.
1548 Lavi et al.t is thus determined by two factors: the obstacles to diffu-
sion that control D, and the size of the original patch R,
which in turn is determined by the dimensions of the region
where the molecules are delivered. We analyze the expected
distribution of lifetimes, as a result of these two possible
contributions, separately.
First possible contribution
1. First we consider the case where the decay times may be
controlled by the variability in D, i.e., by the strength of the
obstructions to diffusion. We can assume that the escape
time from each small trap is given by the usual form (5)
t ¼ t0eDE; (1)
where t0 is the attempt time related to the free diffusion
within the membrane, and DE is the energy barrier (in units
of kBT).
The distribution of barrier heights can be treated as








and to simplify the analysis we take it to apply in the range
N < DE < N. Then the distribution of decay times is
given by











which is essentially a log-normal distribution.Biophysical Journal 102(7) 1543–1550Second possible contribution
2. We now consider a case where the distribution of t is
controlled by the variability in R. The distribution of R is
not known; however, we may explore several processes
that give rise to known distributions:
a. For example, if the distribution of patch sizes is given















which is essentially an exponential distribution.
b. Another possible process discussed in Gov (20), that
could give rise to an interesting distribution of R, is for
a flat circular domain that grows by aggregation along its
rim, while decaying anywhere in its interior. We may think
of a process whereby a membrane domain (or a hole in the
cortical cytoskeleton network) grows by coalescence with
smaller domains (holes) along its rim, but may shrink due
to new cytoskeleton barriers appearing anywhere within
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which is essentially a shifted Gaussian distribution centered
roughly around R0 (compared to Eq. 14). Using this gives
the distribution for t as















At large t this is again an exponential distribution, but it
now has a peak, and throughout most of the measured
regime it decays essentially as expð ﬃﬃtp Þ.
In Fig. 6 we compare these three distributions to the ex-
perimental data (a log-log plot is shown in Fig. S1 in the
Supporting Material, where the behavior at short t can be
more easily observed). Importantly, the equation resulting
from assuming variability inD (Eq. 3) has fitting parameters
involving the energy barrier for crossing the obstacles (DE0)
FIGURE 6 Fitting the data with the resulting distributions. The figure
shows fitting of experimental data with Eq. 3 (solid line), Eq. 5 (dotted
line), and Eq. 7 (triangles) for the treatment with 200 nM Latrunculin
(A), control cells (B), and 20 mM Phalloidin (C). The fitting parameters
for each equation are given in Table 1.
TABLE 1 Fitting parameters for the data shown in Fig. 6





Eq. 3 Eq. 5 Eq. 7
Latrunculin, 200 nM 0.94 3.97 1.1 0.022 0.060 1.4
Control 0.99 4.10 1.1 0.018 0.050 1.4
Phalloidin 200, mM 1.05 4.86 0.9 0.005 0.025 1.5
Uncertainty in the values of the parameters is indicated by the number of
significant digits.
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Thus, when modulating the strength of the actin fences,
we expect to see a change in DE0, consistent with lowering
or raising the energy barriers. On the other hand, Eqs. 5 and
7, resulting from the assumption that variability in R leads to
the distribution of t, have fitting parameters involving D
(the diffusion coefficient). We thus expect to observe a
change in D consistent with the modulation of the actin fen-
ces. We cannot directly extract values for D from this fit,
because we are missing values for the other parameters.
However, in our original model (13) we assumed D ~
109 cm2 s1 for free diffusion and D ~ 1010 cm2 s1 for
hindered diffusion (as measured using FRAP (6)) and calcu-
lated a typical cluster lifetime of ~20 s, in very good agree-
ment with the measured 35–45 s. The diffusion coefficients
underlying the distributions measured here must, thus, be of
the same order of magnitude.
It turns out that the log-normal distribution (Eq. 3) gives a
very good fit with the values of the parameters given in
Table 1. From these values we observe that when Phalloidin
(Latrunculin A) is used to stabilize (destabilize) the actin
filaments, this results in larger (smaller) energy barriers
(DE0) whereas the width of the energy barrier distribution
(aE) is affected very little. Thus, barrier height decreasesfor destabilization, and increases for stabilization of actin
fences.
The behavior at large values of t could, however, also
roughly be fit with an exponential decay (Eq. 5). From the
values in Table 1 we observe that values of D/a2R (corre-
sponding to diffusion coefficients) are larger (faster diffu-
sion) for destabilization and smaller (slower diffusion) for
stabilization of actin filaments. Equation 7 fits better the
data for all values of t (not just large values, like Eq. 5),
although at small values of t it is not as successful as
Eq. 3. Nevertheless, the values of the fitting parameters (in
Table 1) show again lower values of D/a2R (slow diffusion)
for stabilization and higher values (fast diffusion) for desta-
bilization of actin filaments, with a negligible variation of
the initial patch size distribution (determined by the param-
eters R0/aR) across treatments. This initial patch distribution
is presumably determined by the size of the delivery vesi-
cles, and thus is not sensitive to drug treatment of the actin
filaments.
In general, the extent of the effect is smaller for treatment
with Latrunculin A (both for the experimental data and
obviously, as reflected in the fitting parameters) than that
for treatment with Phalloidin, because we limited ourselves
to a maximum concentration of 200 nm for Latrunculin A,
in order not to change the adhesion and shape of the drug-
treated cells.
The two complementary interpretations show that the
treatment with Phalloidin and Latrunculin A either modulate
the diffusion coefficient, or cause a shift in the distribution of
barrier heights for escape. These are consistent interpreta-
tions, in the sense that lowering of the barrier height for
escape results in higher diffusion coefficients and vice versa.
Although variation in barrier height (Eq. 3) alone could
account for the general shape of lifetime distribution, it is
evident that variation in the initial patch size (R0) may have
a significant contribution (Eqs. 5 and 7) as well. We thus
cannot rule out a combination of both factors, leading to
the distribution of lifetimes that we measure.
These results agree with the interpretation that the actin
cytoskeleton contributes to the energy barriers and obstacles
that determine the diffusion of MHC-I in the membrane.
Existence of such dynamic patches of membrane proteins
is thus a necessary outcome of anomalous, confined diffu-
sion, and the natural mechanism of protein traffic to and
from plasma membrane.Biophysical Journal 102(7) 1543–1550
1550 Lavi et al.CONCLUSIONS
Lifetime of MHC-I clusters on the plasma membrane is
controlled by components of the actin cytoskeleton, which
act as obstacles to free diffusion: modulation of the obstacle
strength, using actin-binding drugs, transiently shifts the
distribution of cluster lifetimes in a predictable manner.
The shape of the measured lifetime distribution is ex-
plained by a mathematical model assuming a normal distri-
bution of energy barriers to diffusion, in combination with
possible contributions from a distribution of the initial
dimensions of the MHC-I cluster. The model links between
the shape of lifetime distribution and the barrier height for
free diffusion, thus reinforcing the notion that the dynamic
nature of MHC-I clusters is a necessary outcome of ob-
structed diffusion and vesicle traffic to the plasma
membrane.
Given the biological function of MHC-I (i.e., presentation
of cytosolic peptides to inspection of T-cells, and the
dynamic nature of presentation), it is possible that modula-
tion of the MHC-I cluster lifetime may modulate the recog-
nition of foreign peptides by T-cells.SUPPORTING MATERIAL
A figure is available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(12)00157-9.
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